US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avalyn Pharma

28.11

+1.485.56%

Post-market: 28.110.00000.00%16:10 EDT

Volume:126.14K

Turnover:3.50M

Market Cap:1.18B

PE:-13.79

High:28.61

Open:26.75

Low:26.00

Close:26.63

52wk High:32.23

52wk Low:25.05

Shares:41.81M

Float Shares:16.67M

Volume Ratio:0.41

T/O Rate:0.76%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0380

ROE:-68.34%

ROA:-41.74%

PB:-4.92

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Novo Holdings acquires 555,555 Avalyn Pharma common shares for $10 million

Avalyn presents AP01 eFlow nebulizer usability study data at ATS 2026

Major Insider Moves Signal Growing Confidence in Avalyn Pharma

Avalyn Pharma Closes Initial Public Offering

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVLN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":28.11,"timestamp":1779220800000,"preClose":26.63,"halted":0,"volume":126141,"hourTrading":{"tag":"盘后","latestPrice":28.11,"preClose":28.11,"latestTime":"16:10 EDT","volume":9,"amount":252.99,"timestamp":1779221404333,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0555764175741645,"floatShares":16666700,"shares":41812047,"eps":-2.038,"marketStatus":"Not Yet Opened","change":1.48,"latestTime":"05-19 16:00:00 EDT","open":26.75,"high":28.61,"low":26,"amount":3501633.1842,"amplitude":0.09801,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.038,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":0,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":26.63,"postHourTrading":{"tag":"盘后","latestPrice":28.11,"preClose":28.11,"latestTime":"16:10 EDT","volume":9,"amount":252.99,"timestamp":1779221404333,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.413718},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":0,"volumeRatio":0.413718,"shares":41812047,"dividePrice":0,"high":28.61,"amplitude":0.09801,"preClose":26.63,"low":26,"week52Low":25.05,"pbRate":"-4.92","week52High":32.225,"institutionHeld":0,"latestPrice":28.11,"eps":-2.038,"divideRate":0,"volume":126141,"delay":0,"ttmEps":-2.038,"open":26.75,"prevYearClose":18,"prevWeekClose":29.84,"prevMonthClose":29.49,"prevQuarterClose":18,"fiveDayClose":29.9,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-05-18","current":-13.792934,"percent":0.25,"low":-15.129165,"twenty":-14.66101,"median":-14.471589,"eighty":-13.431244,"high":-8.833116,"avg":-13.837039,"sd":1.567162,"marketCap":1247671482},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-18","current":-14.643344,"twenty":-14.66101,"median":-14.471589,"eighty":-13.431244,"marketCap":1247671482}],"updateTime":1779248995521},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVLN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633299269","title":"Novo Holdings acquires 555,555 Avalyn Pharma common shares for $10 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633299269","media":"Reuters","labels":["insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633299269?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:16","pubTimestamp":1778012202,"startTime":"0","endTime":"0","summary":"Novo Holdings, a 10% owner, lifted its stake in Avalyn Pharma to 3,883,289 voting common shares.Holding increased through conversion of 3,327,734 shares into voting common stock.Novo Holdings also bought 555,555 voting common shares at USD 18 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalyn Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL7C7q1x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novo Holdings acquires 555,555 Avalyn Pharma common shares for $10 million","news_tag":"insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459925","title":"Avalyn presents AP01 eFlow nebulizer usability study data at ATS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459925","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459925?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:03","pubTimestamp":1778011381,"startTime":"0","endTime":"0","summary":"Avalyn Pharma flagged new patient-centered research on AP01 delivery and supportive care experiences, with results scheduled for presentation at American Thoracic Society 2026 International Conference in Orlando on May 18, 2026.A usability study of eFlow nebulizer system for inhaled pirfenidone AP01 found patient, care partner, clinician feedback helped refine instructions intended to improve real-world use.Separate research on idiopathic pulmonary fibrosis supportive care highlighted patient demand for faster, clearer communication, stronger care partner involvement, better access to specialist expertise.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLbFxw9M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SG9999014013.SGD","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2W23.USD","BK4588","LU2210149790.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4112","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","AVLN","BK4585","NDAQ","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632327621","title":"Major Insider Moves Signal Growing Confidence in Avalyn Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2632327621","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632327621?lang=en_us&edition=fundamental","pubTime":"2026-05-02 10:02","pubTimestamp":1777687366,"startTime":"0","endTime":"0","summary":"New insider activity at Avalyn Pharma Inc ( ($AVLN) ) has taken place on May 1, 2026. Avalyn Pharma Inc. has seen notable insider confidence, with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-signal-growing-confidence-in-avalyn-pharma-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-signal-growing-confidence-in-avalyn-pharma-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632475756","title":"Avalyn Pharma Closes Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2632475756","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632475756?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:16","pubTimestamp":1777666562,"startTime":"0","endTime":"0","summary":"Avalyn Pharma (AVLN) said late Friday it has closed its initial public offering of about 19.2 million shares at $18 a share, raising $345 million.The clinical-stage biopharmaceutical company said the closing includes the full exercise of an overallotment option.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPOS","AVLN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVLN\",params:#limit:6,delay:false,,,undefined,":[]}}